ABVC BioPharma Inc

ABVC | $0.9465 0.69% -4.03% |

(0.0% 1d) (-52.2% 1m) (-80.9% 1y) (0.0% 2d) (0.7% 3d) (0.7% 7d) (-38.21% volume)
Earnings Calendar:

Sec Filling | Patents | 34 employees

adhd

add to watch list email alert is off

Price chart

% (High / Open) change chart

Press-releases

ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation
Published: 2022-06-21 (Crawled : 13:20) - biospace.com/
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -2.94% | O: 6.64% H: 0.0% C: 0.0%
partnership biopharma corporation

ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
Published: 2022-06-16 (Crawled : 13:00) - biospace.com/
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -8.11% | O: -4.85% H: 4.08% C: -1.86%
vitargus biopharma australia

ABVC BioPharma Announces Termination of Two Contracts
Published: 2022-06-10 (Crawled : 13:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -49.11% | O: -2.15% H: 0.0% C: 0.0%
biopharma

ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -52.2% | O: -1.01% H: 4.59% C: 3.32%
biopharma for adhd

ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
Published: 2022-05-25 (Crawled : 13:00) - biospace.com/
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -54.05% | O: 0.97% H: 0.96% C: -1.92%
biopharma biotech license

Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
Published: 2022-05-23 (Crawled : 12:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -54.28% | O: 6.76% H: 5.43% C: -2.26%
services depression

ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
Published: 2022-05-16 (Crawled : 22:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -55.35% | O: 3.3% H: 0.0% C: -4.56%
biopharma results

WallachBeth Capital Announces Completion of ABVC BioPharma, Inc. (Nasdaq: ABVC) $4.22 Million Registered Direct Offering
Published: 2022-05-16 (Crawled : 20:00) - prnewswire.com
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -55.35% | O: 3.3% H: 0.0% C: -4.56%
offering nasdaq

ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
Published: 2022-05-13 (Crawled : 13:00) - globenewswire.com
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade

| -59.89% | O: -9.75% H: 7.38% C: 5.63%
biopharma grant funding group

ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Treated
Published: 2022-05-10 (Crawled : 13:20) - biospace.com/
ABVC | $0.9465 0.69% -4.03% |

Wholesale Trade